WEBINAR: Food Allergy Treatment Options for 2025 & Beyond: What You Need to Know
Learn about the latest innovations in food allergy management and therapies.
Tuesday, April 29, 1:00 p.m.–2:00 p.m. ET
Join us at 1 p.m. ET on Tuesday, April 29, to discuss food allergy’s global impact and the recent advancements in treatment options have finally given patients and families options to manage their food allergy. In this webinar, Dr. Sharon Chinthrajah will unveil the latest innovations in allergy management, cutting-edge therapies, and what the future promises for those affected by food allergy.
Healthcare professionals will gain valuable insights into the latest treatments and personalized patient management strategies to improve patient care and optimize interdisciplinary practice with allergists in shared communities.
Caregivers and families can explore new ways to enhance their lives and manage food allergies effectively with emerging options.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAAI and Food Allergy Research & Education (FARE). The AAAAI is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE Designation Statement
The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 1.00 Contact Hours.
About the Speaker
R. Sharon Chinthrajah, MD
R. Sharon Chinthrajah, M.D. is an Associate Professor and the Co-Director of the Sean N. Parker Center for Allergy and Asthma Research at Stanford University. Dr. Chinthrajah received her MD from Drexel University College of Medicine, completed her Internal Medicine training and a chief residency at California Pacific Medical Center, and sub-specialized in Pulmonary/Critical Care and Allergy/Immunology at Boston Medical Center. Her research is focused on developing novel therapeutic options for allergic diseases as well as unraveling the molecular mechanisms driving therapeutic response. She has extensive experience in performing both academic and industry-sponsored clinical trials investigating allergic diseases such as food allergy, atopic dermatitis, eosinophilic esophagitis, asthma, and COVID-19. Her research has led to the publication of over 160 research articles in peer-reviewed journals, including studies that led to the FDA approval of omalizumab for the treatment of food allergy. She is dedicated to training the next generation of clinical researchers and continues to act as a mentor for students and junior faculty interested in pursuing medical research.